A targeted lipid nanoparticle (LNP) delivery platform has been developed for safely and effectively packaging nucleic acid drug payloads, addressing the challenges in RNA-based therapeutics and vaccines. This versatile technology can be utilized for various RNA types and disease indications, enhancing the potential for commercializing RNA drugs.